Arcadia Biosciences (RKDA) Total Current Liabilities (2014 - 2025)

Arcadia Biosciences' Total Current Liabilities history runs 12 years deep, the most recent figure standing at $2.1 million for Q4 2025.

• Quarterly Total Current Liabilities fell 19.66% year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (down 19.66% YoY) and the FY2025 annual result came in at $2.1 million, down 19.66% from the prior year.
• Total Current Liabilities was $2.1 million for Q4 2025 at Arcadia Biosciences, down from $2.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $7.7 million in Q2 2021 and bottomed at $1.8 million in Q2 2025.
• A 5-year average of $3.9 million and a median of $4.0 million in 2022 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2024 — Total Current Liabilities slumped 40.08% — and 2025, when it slipped 1.85%.
• Arcadia Biosciences' Total Current Liabilities stood at $5.0 million in 2021, then fell by 16.49% to $4.2 million in 2022, then retreated by 14.71% to $3.6 million in 2023, then dropped by 28.61% to $2.6 million in 2024, then slipped by 19.66% to $2.1 million in 2025.
• Business Quant data shows RKDA's Total Current Liabilities at $2.1 million in Q4 2025, $2.3 million in Q3 2025, and $1.8 million in Q2 2025.